Buprenorphine implants are noninferior, and may be more effective than sublingual dosing for helping opioid-dependent adults maintain abstinence, according to a report in JAMA (2016;316:282-290).
The rate of response was 8.8% greater among patients who had implants than among those who used sublingual dosing, said first author Richard N. Rosenthal, MD, professor of psychiatry in the Icahn School of Medicine at Mount Sinai, and medical director of addiction psychiatry at Mount Sinai Behavioral